NEWS & ANNOUNCEMENTS ARCHIVE

HASHTAG SEARCH: #cholesterol


BACK TO NEWS
News Story Friday, October 23, 2020

Prime Therapeutics researchers studied hypertension, cholesterol and diabetes medications. See the results here.

They found with a population of over 567,000, sample sizes for each drug category and their associated total cost of care savings – from moving someone with low adherence (<50%) to near perfect adherence (99%+) – was as follows:
- RAS: 132,358 in the sample, achieving $2,901 potential savings PPPY
- Statin: 145,038 in the sample, achieving $1,563 potential savings PPPY
- Diabetes: 40,407 in the sample, achieving $3,365 potential savings PPPY
Additionally, the study found lower odds of hospitalizations and emergency room visits were associated with improved drug category adherence.
https://yhoo.it/2ISbiXa

#primetherapeutics#study#hypertension#cholesterol#diabetes



DAYAMED EXECUTIVE TEAM

SOCIAL MEDIA

Copyright © 2020 Daya Medicals Inc. | PRIVACY | SITEMAP | POWERED BY: CONVEXSTUDIO.CA